Facilitators and barriers to research participation: perspectives of Latinos with type 2 diabetes

Janett A Hildebrand, John Billimek, Ellen F Olshansky, Dara H Sorkin, Jung-Ah Lee, Lorraine S Evangelista, Janett A Hildebrand, John Billimek, Ellen F Olshansky, Dara H Sorkin, Jung-Ah Lee, Lorraine S Evangelista

Abstract

Background: Latinos constitute 17% of the US population and are one of the largest ethnic groups; however, only 7.6% participate in research studies. There is a disproportionately high number of Latinos living with type 2 diabetes mellitus and are at increased risk for cardiovascular events. Research to elicit facilitators and barriers for participation in research and effective recruitment strategies is limited.

Aims: This article reports the qualitative findings of a mixed-methods study examining perceived facilitators and barriers for research participation, and explores decision-making processes and ascertains ethnic values that influenced their decisions among Spanish-speaking Latinos with type 2 diabetes mellitus.

Methods: Semi-structured interviews were conducted with 25 participants (mean age 50.8 ± 9.4 years, 76% women and 28% employed). Participants were asked to elaborate on perceived facilitators and barriers to research participation. All interviews were conducted in Spanish. Transcribed interviews were analyzed through conventional content analysis.

Results: Three themes emerged from transcribed interviews: (a) lowering barriers to access health-related expertise; (b) language concordance; and (c) trusting relationships. Perceived barriers to research participation included work schedule, childcare, transportation and ethnic beliefs.

Conclusion: Strategies to support learning, language concordance and establishing trusting relationships among Spanish-speaking Latinos may be key to increasing Latinos in research studies.

Keywords: Latino; health disparities; research recruitment.

Conflict of interest statement

Declaration of conflicting interests

The authors declare that there is no conflict of interest.

Source: PubMed

3
Abonnere